Clinical Trial Update: A Trial of Triamcinolone With a GnRH Analog for Castration Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports completion of a study evaluating the combination of Triamcinolone with a GnRH analog in patients with castration-resistant pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Gonadotropin-releasing hormone analog (GnRH analog)
• Triamcinolone (triamcinolone)

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Castration Resistant Prostate Cancer | Phase 2 | Status: COMPLETED